A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

KRBP Insider Trading (Kiromic BioPharma)

Insider Ownership Percentage: 3.47%
Insider Buying (Last 12 Months): $10,360.00
Insider Selling (Last 12 Months): $0.00

Kiromic BioPharma Insider Trading History Chart

This chart shows the insider buying and selling history at Kiromic BioPharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Kiromic BioPharma Share Price & Price History

Current Price: $0.39
Price Change: Price Increase of +0.04 (11.43%)
As of 08/10/2022 01:00 AM ET

This chart shows the closing price history over time for KRBP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

Kiromic BioPharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/9/2021Maurizio Chiriva-InternatiCEOBuy2,800$3.70$10,360.001,378,072View SEC Filing Icon  
See Full Table
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

SEC Filings (Institutional Ownership Changes) for Kiromic BioPharma (NASDAQ:KRBP)

16.03% of Kiromic BioPharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at KRBP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Kiromic BioPharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2022Renaissance Technologies LLC56,111$48K0.0%N/A0.360%Search for SEC Filing on Google Icon
5/13/2022Warberg Asset Management LLC73,847$63K0.0%+118.4%0.474%Search for SEC Filing on Google Icon
5/5/2022Lynwood Capital Management Inc.300,000$0.26M0.3%-19.5%1.924%Search for SEC Filing on Google Icon
4/21/2022K.J. Harrison & Partners Inc48,233$41K0.0%+83.9%0.309%Search for SEC Filing on Google Icon
1/26/2022K.J. Harrison & Partners Inc26,233$40K0.0%+54.3%0.170%Search for SEC Filing on Google Icon
12/27/2021Zeke Capital Advisors LLC56,899$0.18M0.0%+236.7%0.369%Search for SEC Filing on Google Icon
11/16/2021Intellectus Partners LLC98,850$0.30M0.1%+32.0%0.640%Search for SEC Filing on Google Icon
11/16/2021Warberg Asset Management LLC12,000$37K0.0%-81.0%0.078%Search for SEC Filing on Google Icon
11/12/20211492 Capital Management LLC434,408$1.33M0.7%+21.3%2.814%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.30,645$94K0.0%+218.3%0.198%Search for SEC Filing on Google Icon
11/5/2021Resources Investment Advisors LLC.10,000$31K0.0%N/A0.065%Search for SEC Filing on Google Icon
11/5/2021K.J. Harrison & Partners Inc17,002$52K0.0%N/A0.110%Search for SEC Filing on Google Icon
10/14/2021WealthTrust Axiom LLC10,000$30K0.0%N/A0.065%Search for SEC Filing on Google Icon
8/17/2021Zeke Capital Advisors LLC16,899$81K0.0%-64.0%0.110%Search for SEC Filing on Google Icon
8/16/2021Warberg Asset Management LLC63,000$0.30M0.1%N/A0.409%Search for SEC Filing on Google Icon
8/16/2021Sabby Management LLC500,508$2.41M0.3%N/A3.253%Search for SEC Filing on Google Icon
8/16/2021Shay Capital LLC25,000$0.12M0.0%N/A0.162%Search for SEC Filing on Google Icon
8/13/2021Altium Capital Management LP333,475$1.60M0.4%N/A2.167%Search for SEC Filing on Google Icon
8/13/2021Murchinson Ltd.100,000$0.48M0.2%N/A0.650%Search for SEC Filing on Google Icon
8/13/2021Intellectus Partners LLC74,900$0.36M0.1%+96.3%0.487%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.119,304$0.57M0.0%+1,045.6%0.775%Search for SEC Filing on Google Icon
8/12/2021Kepos Capital LP767,000$3.69M0.3%N/A4.985%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC21,725$0.20M0.0%+86.7%0.295%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC21,725$0.20M0.0%+86.7%0.296%Search for SEC Filing on Google Icon
5/17/2021Intellectus Partners LLC38,150$0.36M0.1%+8.2%0.520%Search for SEC Filing on Google Icon
5/12/20211492 Capital Management LLC185,937$1.74M1.0%N/A2.536%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.5,117$48K0.0%+45.0%0.070%Search for SEC Filing on Google Icon
5/6/2021Redmond Asset Management LLC45,412$0.43M0.1%N/A0.619%Search for SEC Filing on Google Icon
4/21/2021Zeke Capital Advisors LLC46,999$0.44M0.0%-2.9%0.641%Search for SEC Filing on Google Icon
2/18/2021Intellectus Partners LLC35,250$0.30M0.1%N/A0.481%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.3,529$30K0.0%N/A0.048%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Kiromic BioPharma logo
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement with Leon Office (H.K.) Ltd. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.
Read More on Kiromic BioPharma

Today's Range

Now: $0.39
Low: $0.35
High: $0.40

50 Day Range

MA: $0.41
Low: $0.28
High: $0.57

52 Week Range

Now: $0.39
Low: $0.23
High: $4.60

Volume

128,328 shs

Average Volume

700,206 shs

Market Capitalization

$6.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Kiromic BioPharma?

Kiromic BioPharma's top insider investors include:
  1. Internati Maurizio Chiriva (CEO)
  2. Jerry A Schneider (Director)
Learn More about top insider investors at Kiromic BioPharma.
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!